Pending completion of the acquisition by UnitedHealth Group (NYSE: UNH), Amedisys Inc. (Nasdaq: AMED) to broaden its residence well being care section – ​​primarily by non-Medicare revenues – and its greater emergency care section.

The corporate reported its first-quarter earnings late Wednesday, displaying a ten% improve in whole residence care retailer visits and a 23% year-over-year improve in higher-acuity hospital admissions.

Hospice admissions and revenues, in the meantime, fell barely 12 months on 12 months.

In whole, the corporate introduced in $571.4 million this quarter, up 2.7% from the $556.4 billion it introduced in in the identical interval final 12 months. Residence care revenues elevated from $343.3 million to $360 million, a rise of 6%.

Just like final quarter, Medicare residence care revenues remained roughly flat, whereas non-Medicare revenues soared. Extra particularly, non-Medicare residence care revenues rose to $148.2 million, up practically 16% 12 months over 12 months.

Whereas the important care section noticed this 23% year-over-year improve, revenues from that section had been nonetheless solely $6.4 million within the quarter.

UnitedHealth Group's Optum continues to be anticipated to shut its $3.3 billion all-cash deal for Amedisys by the tip of this 12 months. Though the deal has been carefully watched by the Justice Division, there are causes to imagine {that a} wise divestment technique from Amedisys may convey the deal to fruition.